The Medicines Management Programme (MMP) is currently undertaking an evaluation of the treatment of dry eye syndrome (DES).

As part of this, the MMP is opening a consultation which will run concurrently with the evaluation. The evaluation will include topical eye treatments for DES currently reimbursed under the Community Drug Schemes.

Submissions are invited from all relevant stakeholders and should be emailed to by 5.00 pm Thursday 6th May 2021. Submissions received will be acknowledged by email within 72 hours of receipt. Please contact the MMP if you have not received acknowledgment after this time.

Clinical Design and Innovation